Process for making novel blood clotting enzyme compositions
US4495278A · kind A · utility
43Cited by
9References
87Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Apr 27, 1981 |
| Grant date | Jan 22, 1985 |
| Priority date | — |
| Expiry date | Apr 27, 2001 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Viruses, particularly hepatitis viruses, in blood clotting enzyme compositions are inactivated with little enzyme activity loss by heating the compositions in the dry state. The novel products which result are therapeutically and diagnostically useful.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.